Testing

M LUNG NGS

Lung Cancer NGS

This sequencing panel is useful in determining eligibility for tyrosine kinase inhibitor (TKI) therapy in patients with non-small cell lung cancer (NSCLC). The EGFR mutation is present in 10-15% of…
Learn more
LPD Profile - CLL Profile with CCND1/IGH probe set
Learn more
CD11a, CD11b, CD11c, CD16, CD18, CD14, CD15, CD45
Learn more
Immunophenotyping, myeloid / lymphoid markers by Flow cytometry
Learn more

    Etiam magna arcu, ullamcorper ut pulvinar et, ornare sit amet ligula. Aliquam vitae bibendum lorem. Cras id dui lectus. Pellentesque nec felis tristique urna lacinia sollicitudin ac ac ex. Maecenas mattis faucibus condimentum. Curabitur imperdiet felis at est posuere bibendum. Sed quis nulla tellus.

    ADDRESS

    63739 street lorem ipsum City, Country

    PHONE

    +12 (0) 345 678 9

    EMAIL

    info@company.com